N-Nitroso Edoxaban Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs.N-Nitroso Edoxaban Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 1 chemically represented as 5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridin-2-amine.Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 1 .We supply N-Nitroso Edoxaban Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143156 |
| CAS No | NA |
| Mol.F. | C24H23N7O3 |
| Mol.Wt. | 457.49 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143157 |
| CAS No | NA |
| Mol.F. | C29H27N7O6 |
| Mol.Wt. | 569.58 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143158 |
| CAS No | NA |
| Mol.F. | C30H31N7O7 |
| Mol.Wt. | 601.62 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143159 |
| CAS No | NA |
| Mol.F. | C13H21N3O4 |
| Mol.Wt. | 283.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143160 |
| CAS No | NA |
| Mol.F. | C12H21N3O4 |
| Mol.Wt. | 271.32 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143161 |
| CAS No | NA |
| Mol.F. | C17H18N4O5S |
| Mol.Wt. | 390.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143162 |
| CAS No | NA |
| Mol.F. | C16H16N4O4S |
| Mol.Wt. | 360.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143163 |
| CAS No | NA |
| Mol.F. | C16H16N4O3S |
| Mol.Wt. | 344.39 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143164 |
| CAS No | NA |
| Mol.F. | C16H15ClN4O2S |
| Mol.Wt. | 362.83 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143165 |
| CAS No | NA |
| Mol.F. | C16H16N4O3S |
| Mol.Wt. | 344.39 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143166 |
| CAS No | NA |
| Mol.F. | C15H14N4O2S |
| Mol.Wt. | 314.36 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143167 |
| CAS No | NA |
| Mol.F. | C8H7N3O2S |
| Mol.Wt. | 209.22 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143168 |
| CAS No | NA |
| Mol.F. | C16H16N4O3S |
| Mol.Wt. | 344.39 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143169 |
| CAS No | NA |
| Mol.F. | C17H18N4O3S |
| Mol.Wt. | 358.42 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143170 |
| CAS No | NA |
| Mol.F. | C17H18N4O5S |
| Mol.Wt. | 390.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143171 |
| CAS No | NA |
| Mol.F. | C16H15ClN4O3S |
| Mol.Wt. | 378.83 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |